Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-08-18

Clinical Trial Update: The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts [NA]

View source ↗

Summary

The RETRIEVE study evaluating the FiberNet Embolic Protection System in saphenous vein grafts has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lumen Biomedical | Conditions: Saphenous Vein Graft Disease, Myocardial Ischemia | NA | Status: COMPLETED